Raybow, a premier CDMO specializing in small molecule drug development, stands at the forefront of pharmaceutical innovation. Our main sites have been the process development and lauching sites of 29 innovative drugs, including multiple blockbuster drugs. Our 800+ experienced scientists, armed with in-house unique technology platforms, position us to collaborate read morewith emerging biotech firms and MNC pharma clients, guiding projects from medicinal chemistry all the way to full-scale commercialization. [website]

Regis Custom Pharma is a US-based contract development and manufacturing organization focused on the development and manufacture of New Chemical Entities. We offer a comprehensive range of drug substance development services to support the development of lead molecules from preclinical through commercialization including Process Chemistry, Analytical Method Development read moreand Validation, Solid State Chemistry, Micronization, cGMP Manufacturing, Process Validation, and Stability Services. All development and manufacturing of small molecule APIs occur at our US-based site centrally located in the Chicagoland area. Regis is privately owned and operated and has been in business since 1956.